September 2019
TABLE OF CONTENTSCluster's lifeOur member's newsSave the dateCalls for projects

On October 15th, the cluster team will be happy to welcome you at the Hôtel de Région in Lyon for the 13th Partnering Day. The format of the event is brand new. You will be able to meet public funders located in the exhibition village, discover companies and projects looking for partners or participate in BtoB in addition to the 10 brainstorming round tables presented this year ! Register online.

 

Two other key events will close this year: the Private Investment Day on November, 29 and then I4ID2019 - Immunotherapies & Innovations for Infectious Diseases Congress 2019 on December, 4th at the ENS in Lyon. This event co-organized with MabDesign and BIOASTER is the merger of I4ID and the Nosocomial Infections Day! A rich two-day program to discover.

Cluster's life

 Success for Lyonbiopole with the Public-Private Day of the Congress on Health NutritionThe 4th edition of the Congress on Nutrition and Health, whose central theme was "Metabolic Health and Nutrition", co-organized by Lyonbiopole and its partner CENS, was held on September 11. More than 100 participants took part in this day. This success illustrates Lyonbiopole's work, which has succeeded in bringing together regional, national and international players around the Nutrition and Health axis, combining both academic and industrial sectors.
 AN UNPRECEDENTED SUPPORT INITIATED BY LYONBIOPOLE FOR 11 MEDTECH COMPANIESThe regulatory developments relating to CE marking in the medical technology sector are worrying the companies concerned. Lyonbiopole, the Auvergne-Rhône-Alpes Region, the Auvergne Rhône-Alpes Entreprises Agency and Snitem have set up for the first time in France a support system for medtech SMEs in their compliance with this new European regulation. 11 companies, including 6 members of the cluster (3S Ortho, Bioxis, MagIA Diagnostics, Modjaw, Noraker, TMM Software) will receive individual support and a total of €200,000 in financial assistance to achieve this.
 Lyonbiopole and its partners organize their first S3martMed networking event at the University Hospital of Tübingen As part of its European S3martMed project, Lyonbiopole and its partners organized a Europe-wide networking event dedicated to medical technologies. Renowned clinicians performed surgical operations live, exposing their needs for new technologies and equipment. The next day, 2 thematic round tables led by experts in 3D printing and artificial intelligence and a BtoB schedule allowed participants to get informed and exchange ideas for future collaborations. The 2nd event will be held in the 1st quarter of 2020 in Lyon.
 AYMING: PARTNER OF THE PARTNERING DAY Ayming, a privileged partner of companies wishing to strengthen their innovation policy, responds to 7 major challenges: - Provide a strategic vision of innovation, - Provide the best data to make the best decisions, - Support customers to better govern, organize, manage and launch projects, - Financing and securing your innovation projects: Tax Credits (CIR, CII, JEI) and innovation financing, - Improve your processes for managing and leading collaborative projects, - Encourage the selection and hiring of the best scientific resources, - Develop the commitment of your employees. Meet them in the exhibition village during the Partnering Day on October 15th.

Our member's news

 New membersDiscover the new members of Lyonbiopole: Biosency is developing a remote monitoring solution to improve the care path of patients with respiratory insufficiency, ICARE is a service provider, an expert in contamination control for industrial health actors and finally SIBIUS is interested in neurocognitive disorders thanks to an original approach. [...]
 Focus onKeranova raises €24M in second round of financing.Funds will enable company to finalize regulatory process with view to obtaining CE mark for ultra-fast robotized ophthalmology laser.
 September 3th, 2019VALBIOTIS announces positive results from the Phase IIA clinical study of VALEDIA September 3th, 2019THERANEXUS announces the publication of two scientific papers and a presentation at the EFIC September 3th, 2019ORPHELIA Pharma announces Orphan Drug Designation granted by EMA for temozolomide
 September 9th, 2019PDC*line Pharma welcomes Dr Channa Debruyne to its management team September 12th, 2019MaaT Pharma expands executive team September 16th, 2019GeNeuro's temelimab shows extended neuroprotective effects in relapsing-remitting MS
 September 17th, 2019VALBIOTIS presents positive results from a study on TOTUM-63, active substance of VALEDIA September 17th, 2019Theranexus announces inclusion of last subject in its phase 1b trial of THN201 September 17th, 2019Poxel Initiates Phase 1b Multiple Ascending Dose (MAD) Trial for NASH Drug Candidate, PXL065
 September 17th, 2019Agatha Raises USD 4 Million for Life-science Content Management Cloud September 17th, 2019Indicia Production announces acquisition of Bio-Steril September 18th, 2019Inovotion is once again working with the NC3Rs' CRACK IT Solutions technology partnering programme to showcase our technology
 September 25th, 2019Theranexus: inclusion of last patient in phase 2 trial for THN201 in Parkinson’s patients September 30th, 2019Biofilm: a major issue on public healthcare by BIOASTER

Save the date

 International Mission Health Nutrition
October 14th, 2019
Partnering Day 2019
October 15th, 2019
Convention BIO-Europe 2019
November 11th, 2019
Private Inv€stment Day 2019
November 29th, 2019
I4ID2019 - Immunotherapies & Innovations for Infectious Diseases Congress 2019
Décember 4th, 2019
  • MEDICA 2019
    November 18th, 2019

  • See All events

    Calls for projects

     

    EUROPE & INTERNATIONAL

  • Fast track to innovation
    Before October 22th, 2019
  • H2020 Health – Last calls Open
    Before April 22th, 2020
  • Bâtiment Domilyon

    321, avenue Jean Jaurès

    69007 Lyon

    Tel. : +33 (0)4 72 76 53 30

    Fax : +33 (0)9 55 91 30 26

    www.lyonbiopole.com

    info@lyonbiopole.com

    TwitterLinkedInrss

     

    This email has been sent automatically to [[EMAIL_TO]]. Click here to unsubscribe.